Skip to main content
Erschienen in: Neurological Sciences 2/2020

03.10.2019 | Original Article

Sarcopenia, dynapenia, and body composition in Parkinson’s disease: are they good predictors of disability?: a case–control study

verfasst von: Firuzan Fırat Ozer, Sibel Akın, Murat Gultekin, Gozde Erturk Zararsız

Erschienen in: Neurological Sciences | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background/aim

To assess sarcopenia and dynapenia and their relationship with disease severity and disabilities in PD and to state body composition in PD.

Methods

We conducted a case–control, cross-sectional study that included 70 patients with idiopathic PD and 85 controls. Sarcopenia was defined according to the European Working Group on Sarcopenia in Older People (EWGSOP) criteria. Dynapenia was detected by a handheld dynamometer. Bioimpedance analysis (BIA) was performed, and the SARC-F questionnaire was applied. Disabilities were appointed according to the Katz and Lawton indexes.

Results

Sarcopenia and dynapenia were more prevalent in PD than in controls (50 vs 30.6% and 31.4 vs 17.6%, respectively). Dynapenia was significantly associated with the severity of the disease and disabilities (p = 0.047, p = 0.001); however, sarcopenia was not. The skeletal muscle mass index (SMMI), fat mass index (FMI), and fat-free mass index (FFMI) did not differ between the PD and controls. FMI was lower in the advanced stages of the disease. Higher scores in the SARC-F questionnaire were significantly associated with disabilities and the severity of the disease (p < 0.001, p < 0.001).

Conclusion

Muscle strength was closely associated with the severity of the disease and disabilities in PD, but muscle mass was not. Sarcopenia, defined by the SARC-F questionnaire, was a good predictor of disabilities in PD, while the EWGSOP criteria were not. PD patients have a favorable body composition even in advanced stages of the disease with lower FMI and protected lean mass.
Literatur
1.
Zurück zum Zitat Shulman LM (2010) Understanding disability in Parkinson's disease. Mov Disord 25:131–135CrossRef Shulman LM (2010) Understanding disability in Parkinson's disease. Mov Disord 25:131–135CrossRef
2.
Zurück zum Zitat Lauretani F, Maggio M, Silvestrini C, Nardelli A, Saccavini M, Ceda GP (2012) Parkinson's disease (PD) in the elderly: an example of geriatric syndrome (GS)? Arch Gerontol Geriatr 54:242–246CrossRef Lauretani F, Maggio M, Silvestrini C, Nardelli A, Saccavini M, Ceda GP (2012) Parkinson's disease (PD) in the elderly: an example of geriatric syndrome (GS)? Arch Gerontol Geriatr 54:242–246CrossRef
3.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010l) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423CrossRef Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010l) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423CrossRef
4.
Zurück zum Zitat Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R (2004) Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159:413–421CrossRef Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R (2004) Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159:413–421CrossRef
5.
Zurück zum Zitat Lauretani F, Bautmans I, De Vita F et al (2014) Identification and treatment of older persons with sarcopenia. Aging Male 17:199–204CrossRef Lauretani F, Bautmans I, De Vita F et al (2014) Identification and treatment of older persons with sarcopenia. Aging Male 17:199–204CrossRef
6.
Zurück zum Zitat Drey M, Hasmann SE, Krenovsky JP et al (2017) Associations between early markers of Parkinson's disease and sarcopenia. Front Aging Neurosci 9:53CrossRef Drey M, Hasmann SE, Krenovsky JP et al (2017) Associations between early markers of Parkinson's disease and sarcopenia. Front Aging Neurosci 9:53CrossRef
7.
Zurück zum Zitat Barichella M, Pinelli G, Iorio L, Cassani E, Valentino A, Pusani C, Ferri V, Bolliri C, Pasqua M, Pezzoli G, Frazzitta G, Cereda E (2016) Sarcopenia and dynapenia in patients with parkinsonism. J Am Med Dir Assoc 17:640–646CrossRef Barichella M, Pinelli G, Iorio L, Cassani E, Valentino A, Pusani C, Ferri V, Bolliri C, Pasqua M, Pezzoli G, Frazzitta G, Cereda E (2016) Sarcopenia and dynapenia in patients with parkinsonism. J Am Med Dir Assoc 17:640–646CrossRef
8.
Zurück zum Zitat Vetrano DL, Pisciotta MS, Laudisio A, Lo Monaco MR, onder G, Brandi V, Fusco D, di Capua B, Ricciardi D, Bernabei R, Zuccalà G (2018) Sarcopenia in Parkinson disease: comparison of different criteria and association with disease severity. J Am Med Dir Assoc 19:523–527CrossRef Vetrano DL, Pisciotta MS, Laudisio A, Lo Monaco MR, onder G, Brandi V, Fusco D, di Capua B, Ricciardi D, Bernabei R, Zuccalà G (2018) Sarcopenia in Parkinson disease: comparison of different criteria and association with disease severity. J Am Med Dir Assoc 19:523–527CrossRef
9.
Zurück zum Zitat Yazar T, Yazar HO, Zayimoğlu E, Çankaya S (2018 Aug) Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease. Neurol Sci 39(8):1415–1421CrossRef Yazar T, Yazar HO, Zayimoğlu E, Çankaya S (2018 Aug) Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease. Neurol Sci 39(8):1415–1421CrossRef
10.
Zurück zum Zitat Tan AH, Hew YC, Lim SY, Ramli NM, Kamaruzzaman SB, Tan MP, Grossmann M, Ang BH, Tan JY, Manap MAAA, Tay TK, Tan SL, New RP, Fadzli F, Yee EJ, Moy FM, Mahadeva S, Lang AE (2018) Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease. Parkinsonism Relat Disord 56:58–64CrossRef Tan AH, Hew YC, Lim SY, Ramli NM, Kamaruzzaman SB, Tan MP, Grossmann M, Ang BH, Tan JY, Manap MAAA, Tay TK, Tan SL, New RP, Fadzli F, Yee EJ, Moy FM, Mahadeva S, Lang AE (2018) Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease. Parkinsonism Relat Disord 56:58–64CrossRef
11.
Zurück zum Zitat Janssen I, Heymsfield SB, Baumgartner RN, Ross R (2000) Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 89:465–471CrossRef Janssen I, Heymsfield SB, Baumgartner RN, Ross R (2000) Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 89:465–471CrossRef
12.
Zurück zum Zitat Malmstrom TK, Morley JE (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14:531–532CrossRef Malmstrom TK, Morley JE (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14:531–532CrossRef
13.
Zurück zum Zitat Bahat G, Yilmaz O, Kılıç C et al (2018) Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging 22:898–903CrossRef Bahat G, Yilmaz O, Kılıç C et al (2018) Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging 22:898–903CrossRef
14.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRef Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRef
15.
Zurück zum Zitat Bahat G, Tufan A, Tufan F, Kilic C, Akpinar TS, Kose M, Erten N, Karan MA, Cruz-Jentoft AJ (2016) Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 35:1557–1563CrossRef Bahat G, Tufan A, Tufan F, Kilic C, Akpinar TS, Kose M, Erten N, Karan MA, Cruz-Jentoft AJ (2016) Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 35:1557–1563CrossRef
16.
17.
Zurück zum Zitat Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 9:179–186CrossRef Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 9:179–186CrossRef
18.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427–442CrossRef Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427–442CrossRef
19.
Zurück zum Zitat Cereda E, Cassani E, Barichella M, Spadafranca A, Caccialanza R, Bertoli S, Battezzati A, Pezzoli G (2012) Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution. Clin Nutr 31:699–704CrossRef Cereda E, Cassani E, Barichella M, Spadafranca A, Caccialanza R, Bertoli S, Battezzati A, Pezzoli G (2012) Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution. Clin Nutr 31:699–704CrossRef
20.
Zurück zum Zitat van der Marck MA, Dicke HC, Uc EY, Kentin ZHA, Borm GF, Bloem BR, Overeem S, Munneke M (2012) Body mass index in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord 18:263–267CrossRef van der Marck MA, Dicke HC, Uc EY, Kentin ZHA, Borm GF, Bloem BR, Overeem S, Munneke M (2012) Body mass index in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord 18:263–267CrossRef
21.
Zurück zum Zitat Bernhardt D, Müller HP, Ludolph AC, Dupuis L, Kassubek J (2016) Body fat distribution in Parkinson's disease: an MRI-based body fat quantification study. Parkinsonism Relat Disord 33:84–89CrossRef Bernhardt D, Müller HP, Ludolph AC, Dupuis L, Kassubek J (2016) Body fat distribution in Parkinson's disease: an MRI-based body fat quantification study. Parkinsonism Relat Disord 33:84–89CrossRef
22.
Zurück zum Zitat Wills AM, Pérez A, Wang J, Su X, Morgan J, Rajan SS, Leehey MA, Pontone GM, Chou KL, Umeh C, Mari Z, Boyd J, NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators (2016) Association between change in body mass index, unified Parkinson's disease rating scale scores, and survival among persons with Parkinson disease: secondary analysis of longitudinal data from NINDS exploratory trials in Parkinson disease long-term study 1. JAMA Neurol 73:321–328CrossRef Wills AM, Pérez A, Wang J, Su X, Morgan J, Rajan SS, Leehey MA, Pontone GM, Chou KL, Umeh C, Mari Z, Boyd J, NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators (2016) Association between change in body mass index, unified Parkinson's disease rating scale scores, and survival among persons with Parkinson disease: secondary analysis of longitudinal data from NINDS exploratory trials in Parkinson disease long-term study 1. JAMA Neurol 73:321–328CrossRef
23.
Zurück zum Zitat Beyer PL, Palarino MY, Michalek D et al (1995) Weight change and body composition in patients with Parkinson’s disease. J Am Diet Assoc 95:979–983CrossRef Beyer PL, Palarino MY, Michalek D et al (1995) Weight change and body composition in patients with Parkinson’s disease. J Am Diet Assoc 95:979–983CrossRef
24.
Zurück zum Zitat Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F, Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators (2013) Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson's disease. Mov Disord 28:1064–1071CrossRef Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F, Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators (2013) Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson's disease. Mov Disord 28:1064–1071CrossRef
25.
Zurück zum Zitat Balogun S, Winzenberg T, Wills K, Scott D, Jones G, Aitken D, Callisaya ML (2017) Prospective associations of low muscle mass and function with 10-year falls risk, incident fracture and mortality in community-dwelling older adults. J Nutr Health Aging 21:843–848CrossRef Balogun S, Winzenberg T, Wills K, Scott D, Jones G, Aitken D, Callisaya ML (2017) Prospective associations of low muscle mass and function with 10-year falls risk, incident fracture and mortality in community-dwelling older adults. J Nutr Health Aging 21:843–848CrossRef
Metadaten
Titel
Sarcopenia, dynapenia, and body composition in Parkinson’s disease: are they good predictors of disability?: a case–control study
verfasst von
Firuzan Fırat Ozer
Sibel Akın
Murat Gultekin
Gozde Erturk Zararsız
Publikationsdatum
03.10.2019
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 2/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-04073-1

Weitere Artikel der Ausgabe 2/2020

Neurological Sciences 2/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.